262 related articles for article (PubMed ID: 16009905)
1. Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.
Baumann CR; Stocker R; Imhof HG; Trentz O; Hersberger M; Mignot E; Bassetti CL
Neurology; 2005 Jul; 65(1):147-9. PubMed ID: 16009905
[TBL] [Abstract][Full Text] [Related]
2. Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study.
Baumann CR; Werth E; Stocker R; Ludwig S; Bassetti CL
Brain; 2007 Jul; 130(Pt 7):1873-83. PubMed ID: 17584779
[TBL] [Abstract][Full Text] [Related]
3. Retrograde study of hypocretin-1 (orexin-A) projections to subdivisions of the dorsal raphe nucleus in the rat.
Lee HS; Park SH; Song WC; Waterhouse BD
Brain Res; 2005 Oct; 1059(1):35-45. PubMed ID: 16153616
[TBL] [Abstract][Full Text] [Related]
4. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
[TBL] [Abstract][Full Text] [Related]
5. [Hypocretin disturbance and sleep disorders].
Billiard M
Bull Acad Natl Med; 2011 Oct; 195(7):1567-78; discussion 1579-81. PubMed ID: 22812161
[TBL] [Abstract][Full Text] [Related]
6. CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.
Van Rooij FG; Schelhaas HJ; Lammers GJ; Verbeek MM; Overeem S
Amyotroph Lateral Scler; 2009; 10(5-6):487-9. PubMed ID: 19922146
[TBL] [Abstract][Full Text] [Related]
7. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
[TBL] [Abstract][Full Text] [Related]
8. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders.
Mignot E; Taheri S; Nishino S
Nat Neurosci; 2002 Nov; 5 Suppl():1071-5. PubMed ID: 12403989
[TBL] [Abstract][Full Text] [Related]
9. Hypocretin/orexin disturbances in neurological disorders.
Fronczek R; Baumann CR; Lammers GJ; Bassetti CL; Overeem S
Sleep Med Rev; 2009 Feb; 13(1):9-22. PubMed ID: 18819824
[TBL] [Abstract][Full Text] [Related]
10. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
[TBL] [Abstract][Full Text] [Related]
11. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.
Blouin AM; Thannickal TC; Worley PF; Baraban JM; Reti IM; Siegel JM
Neurology; 2005 Oct; 65(8):1189-92. PubMed ID: 16135770
[TBL] [Abstract][Full Text] [Related]
12. Hypocretins (orexins) and sleep-wake disorders.
Baumann CR; Bassetti CL
Lancet Neurol; 2005 Oct; 4(10):673-82. PubMed ID: 16168936
[TBL] [Abstract][Full Text] [Related]
13. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
[TBL] [Abstract][Full Text] [Related]
14. Hypocretin (orexin) loss in Parkinson's disease.
Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
[TBL] [Abstract][Full Text] [Related]
15. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis.
Sakurai T
Sleep Med Rev; 2005 Aug; 9(4):231-41. PubMed ID: 15961331
[TBL] [Abstract][Full Text] [Related]
16. Narcolepsy: selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies.
Bassetti CL
Neurology; 2005 Oct; 65(8):1152-3. PubMed ID: 16247037
[No Abstract] [Full Text] [Related]
17. Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.
Terao A; Haruyama T; Kimura K
Jpn J Vet Res; 2008 Jan; 55(2-3):75-83. PubMed ID: 18318109
[TBL] [Abstract][Full Text] [Related]
18. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH).
Dohi K; Ripley B; Fujiki N; Ohtaki H; Shioda S; Aruga T; Nishino S
Peptides; 2005 Nov; 26(11):2339-43. PubMed ID: 15893406
[TBL] [Abstract][Full Text] [Related]
19. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
Baumann CR; Bassetti CL
Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamus, hypocretins/orexin, and vigilance control.
Nishino S
Handb Clin Neurol; 2011; 99():765-82. PubMed ID: 21056227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
